Find your path to Dylan
248 people in our graph share verified history with Dylan — schools, employers, funds. One of them is your warm intro.
Lauren ArribasunlockedDylan: together at The Wharton School (2020)
×8Dylan: together at The Wharton School
×2Dylan: together at Connecticut College
Dylan: together at UCD Michael Smurfit Graduate Business School
About
Dylan Matzinger serves as Chief Business Officer at Novotech. He has a background in commercial and business leadership within the CRO and biopharma industry, including building and leading cross-functional teams.
Chief Business Officer at Novotech
Intro paths
→
In turn, Dylan can intro founders to Novotech's investors below.
Novotech's investors · 4
Experience
- NovotechChief Business Officercurrent2026 — presentUnited States
- ERGOMEDExecutive Vice President, Business Development & Commercial Operations2025 — 2026United States
- ICON plcSr. Vice President, Business Development2023 — 2025United States
- ICON plcSr. Vice President, Commercial Operations2023United States
- ICON plcGlobal Vice President, Business Development - Pharma Solutions2021 — 2023San Diego, California, United States
- ICON plcVice President, Business Development2019 — 2021San Diego, California, United States
- ICON plcExecutive Director, Business Development2016 — 2019San Diego County, California, United States
- ICON plcSenior Director, Business Development2015 — 2016
- ICON plcDirector, Business Development2013 — 2015San Francisco Bay Area
- QuintilesBusiness Development and Operations2007 — 2013San Diego County, California, United States
Skills & more
Clinical Trials50ICH-GCP9Clinical Research22New Business Development6Proposal Writing12Proposal Generation4Relationship Management4Sales11Sales Process3Business Development13Global Business Development4Clinical Development40
+11 more
Sales EffectivenessDrug DevelopmentClinical Data ManagementBiotechnologyEDCTherapeutic AreasMedical DevicesGCPPharmaceutical IndustryCTMSClinical Trial Management System (CTMS)Languages Spanish
From Dylan's professional profile.
Frequently asked questions
- Who is Dylan Matzinger?
- Dylan Matzinger serves as Chief Business Officer at Novotech. He has a background in commercial and business leadership within the CRO and biopharma industry, including building and leading cross-functional teams.
- Where does Dylan Matzinger work?
- Dylan Matzinger is Chief Business Officer at Novotech.
- Where did Dylan Matzinger go to school?
- Dylan Matzinger studied at UCD Michael Smurfit Graduate Business School (Executive Development, Leading with Impact); The Wharton School (Aresty Institute of Executive Education, Customer Centricity); UCD Michael Smurfit Graduate Business School (Executive Development, Organizational Leadership).
Same school
Also attended UCD Michael Smurfit Graduate Business School41
Wayne ByrneVenture Partner at BURNT ISLAND VENTURESJack McGuinnessInvestor at HV CapitalNorbert MuschongManaging Partner at Vorwerk VenturesSascha GüntherPartner at Vorwerk VenturesJennifer McMahonPartner at Seroba Life SciencesBrian CummingsInvestment Director at Clarendon Fund Managers Ltd.
+ 35 more
Also attended The Wharton School2,000
Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst
+ 1,994 more
Also attended Connecticut College49
Chloë McAuleyExecutive Assistant at March Capital PartnersBinsen LiPrincipal at MPM BioImpactTravis ConnorsCo-founder and General Partner at Building VenturesWesley MorrisInvestor at Silversmith Capital PartnersSahil SachdevDirector of Venture Design at Founders FactoryAmy CheethamPartner at Costanoa Ventures
+ 43 more
Shared employers
Also worked at Novotech5
Also worked at ERGOMED1
Also worked at ICON plc21
Ryan BethencourtManaging Partner at Sustainable Food VenturesGabe LaurenceAssociate at CU Healthcare Innovation FundElizabeth YarberSenior Director of Clinical Operations at AOA DxKim EkroosScientific Advisor at AOA DxGeorge McMillanSenior Advisor at InTandem Capital PartnersIra SpectorFounder at SFA Therapeutics
+ 15 more
Also worked at Quintiles84
Scott DonohueSenior Director, Market Access at Deerfield Management CompanyAlain HuriezVenture Partner at Advent Life SciencesDana Marohn SpiliotisPartner at Operator CollectiveRoel DekkersInvestment manager at NoaberMaulik MehtaManaging Partner at Excelerate Health VenturesJeanne HechtDigital Pharma Advisor at Excelerate Health Ventures
+ 78 more